These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27038380)

  • 1. Preface.
    Donev R
    Adv Protein Chem Struct Biol; 2016; 104():xiii-xv. PubMed ID: 27038380
    [No Abstract]   [Full Text] [Related]  

  • 2. An interview with Min Li, Ph.D. Interviewed by Vicki Glaser.
    Li M
    Assay Drug Dev Technol; 2010 Dec; 8(6):631-7. PubMed ID: 21158682
    [No Abstract]   [Full Text] [Related]  

  • 3. [Development by researchers in academia of disease modifying drugs for neurological disorders].
    Ikeda S; Iwata A
    Rinsho Shinkeigaku; 2010 Nov; 50(11):837. PubMed ID: 21921463
    [No Abstract]   [Full Text] [Related]  

  • 4. A-to-I RNA editing modulates the pharmacology of neuronal ion channels and receptors.
    Streit AK; Decher N
    Biochemistry (Mosc); 2011 Aug; 76(8):890-9. PubMed ID: 22022962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of Automated Technologies to Ion Channel Drug Discovery.
    Picones A; Loza-Huerta A; Segura-Chama P; Lara-Figueroa CO
    Adv Protein Chem Struct Biol; 2016; 104():357-378. PubMed ID: 27038379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Epigenetic Therapies in Neuroscience: Focus on Bromodomain-Containing Drug Targets.
    Wahlestedt C
    Neuropsychopharmacology; 2017 Jan; 42(1):374. PubMed ID: 27909334
    [No Abstract]   [Full Text] [Related]  

  • 7. Channeling drug discovery.
    Steinhagen H; Damann N
    ChemMedChem; 2012 Oct; 7(10):1695-7. PubMed ID: 23001972
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeting voltage-gated calcium channels in neurological and psychiatric diseases.
    Zamponi GW
    Nat Rev Drug Discov; 2016 Jan; 15(1):19-34. PubMed ID: 26542451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The multiple personalities of h-channels.
    Santoro B; Baram TZ
    Trends Neurosci; 2003 Oct; 26(10):550-4. PubMed ID: 14522148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ion channel drug discovery: challenges and future directions.
    Wickenden A; Priest B; Erdemli G
    Future Med Chem; 2012 Apr; 4(5):661-79. PubMed ID: 22458684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ion channel mutations in neuronal diseases: a genetics perspective.
    Steinlein OK
    Chem Rev; 2012 Dec; 112(12):6334-52. PubMed ID: 22607259
    [No Abstract]   [Full Text] [Related]  

  • 12. [KCC2: a new therapeutical target for the treatment of neurological diseases].
    Bergeron MJ; Castonguay A; De Koninck Y
    Med Sci (Paris); 2014 May; 30(5):514-7. PubMed ID: 24939537
    [No Abstract]   [Full Text] [Related]  

  • 13. Ephs and ephrins: emerging therapeutic targets in neuropathology.
    Attwood BK; Patel S; Pawlak R
    Int J Biochem Cell Biol; 2012 Apr; 44(4):578-81. PubMed ID: 22265656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interdisciplinary chemical approaches for neuropathology.
    Ramsay RR; Di Giovanni G
    CNS Neurosci Ther; 2014 Jul; 20(7):571-3. PubMed ID: 24935786
    [No Abstract]   [Full Text] [Related]  

  • 15. Ion channels as therapeutic targets: a drug discovery perspective.
    Bagal SK; Brown AD; Cox PJ; Omoto K; Owen RM; Pryde DC; Sidders B; Skerratt SE; Stevens EB; Storer RI; Swain NA
    J Med Chem; 2013 Feb; 56(3):593-624. PubMed ID: 23121096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders.
    Ye N; Neumeyer JL; Baldessarini RJ; Zhen X; Zhang A
    Chem Rev; 2013 May; 113(5):PR123-78. PubMed ID: 23464812
    [No Abstract]   [Full Text] [Related]  

  • 17. Challenges in Neuropharmacology.
    Cascorbi I
    Clin Pharmacol Ther; 2019 May; 105(5):1050-1053. PubMed ID: 30986334
    [No Abstract]   [Full Text] [Related]  

  • 18. Ontologies of drug discovery and design for neurology, cardiology and oncology.
    Vázquez-Naya JM; Martínez-Romero M; Porto-Pazos AB; Novoa F; Valladares-Ayerbes M; Pereira J; Munteanu CR; Dorado J
    Curr Pharm Des; 2010; 16(24):2724-36. PubMed ID: 20642429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preface.
    Donev R
    Adv Protein Chem Struct Biol; 2018; 111():xi. PubMed ID: 29459037
    [No Abstract]   [Full Text] [Related]  

  • 20. Ligand-gated ion channels: new insights into neurological disorders and ligand recognition.
    Lemoine D; Jiang R; Taly A; Chataigneau T; Specht A; Grutter T
    Chem Rev; 2012 Dec; 112(12):6285-318. PubMed ID: 22988962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.